Phlda3 regulates beta cell survival during stress.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
06 09 2019
Historique:
received: 21 02 2019
accepted: 19 08 2019
entrez: 8 9 2019
pubmed: 8 9 2019
medline: 23 10 2020
Statut: epublish

Résumé

The loss of functional beta cell mass characterises all forms of diabetes. Beta cells are highly susceptible to stress, including cytokine, endoplasmic reticulum (ER) and oxidative stress. This study examined the role of pleckstrin homology-like, domain family A, member 3 (Phlda3) in beta cell survival under stress conditions and the regulatory basis. We found that the mRNA levels of Phlda3 were markedly upregulated in vivo in the islets of diabetic humans and mice. In vitro, exposure of MIN6 cells or islets to cytokines, palmitate, thapsigargin or ribose upregulated Phlda3 mRNA and protein levels, concurrent with the induction of ER stress (Ddit3 and Trb3) and antioxidant (Hmox1) genes. Furthermore, H

Identifiants

pubmed: 31492921
doi: 10.1038/s41598-019-49289-5
pii: 10.1038/s41598-019-49289-5
pmc: PMC6731300
doi:

Substances chimiques

Antioxidants 0
Cytokines 0
Endoplasmic Reticulum Chaperone BiP 0
HSPA5 protein, human 0
Hspa5 protein, mouse 0
NF-kappa B 0
Nuclear Proteins 0
RNA, Messenger 0
TSSC3 protein 0
X-Box Binding Protein 1 0
Palmitic Acid 2V16EO95H1
Thapsigargin 67526-95-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12827

Références

Diabetes. 2002 Feb;51(2):311-6
pubmed: 11812737
Diabetologia. 2016 Jul;59(7):1492-1502
pubmed: 27039902
Diabetes. 2013 May;62(5):1557-68
pubmed: 23274897
Mol Cell Endocrinol. 2012 Nov 25;364(1-2):1-27
pubmed: 22885162
J Endocrinol. 2008 Dec;199(3):407-16
pubmed: 18818302
FEBS Lett. 1996 Apr 29;385(1-2):4-6
pubmed: 8641463
FEBS Lett. 2012 Aug 14;586(17):2662-73
pubmed: 22728242
Diabetes. 2014 Jun;63(6):1978-93
pubmed: 24379348
Endocr Rev. 2008 May;29(3):317-33
pubmed: 18436705
Cell. 2009 Feb 6;136(3):535-50
pubmed: 19203586
Mol Cell Endocrinol. 2015 Sep 15;413:189-201
pubmed: 26135354
Diabetologia. 2007 Apr;50(4):752-63
pubmed: 17268797
Biochim Biophys Acta. 2010 Mar;1801(3):289-98
pubmed: 19715772
Cell Metab. 2017 Apr 04;25(4):898-910.e5
pubmed: 28380379
Trends Endocrinol Metab. 2014 Aug;25(8):389-98
pubmed: 24656915
PLoS One. 2017 Nov 9;12(11):e0187927
pubmed: 29121094
Cell Metab. 2019 Jul 2;30(1):129-142.e4
pubmed: 31155496
Diabetes Obes Metab. 2009 Nov;11 Suppl 4:65-81
pubmed: 19817790
Methods Mol Biol. 2012;879:351-66
pubmed: 22610570
Endocrinology. 1990 Jul;127(1):126-32
pubmed: 2163307
J Clin Invest. 2002 Feb;109(4):525-32
pubmed: 11854325
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12363-8
pubmed: 12218186
Gut. 2016 Aug;65(8):1377-88
pubmed: 25966993
Diabetologia. 2015 Apr;58(4):758-70
pubmed: 25636209
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10845-50
pubmed: 11526215
Int J Cancer. 2009 Dec 15;125(12):2863-70
pubmed: 19609947
J Clin Invest. 2008 Oct;118(10):3378-89
pubmed: 18776938
Nat Rev Endocrinol. 2009 Apr;5(4):219-26
pubmed: 19352320
Diabetes. 2013 Jan;62(1):158-69
pubmed: 22961087
Diabetologia. 1998 Sep;41(9):1101-8
pubmed: 9754830
Endocr Rev. 2008 Feb;29(1):42-61
pubmed: 18048764
Diabetologia. 2007 Jul;50(7):1442-52
pubmed: 17497122
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):E2404-13
pubmed: 24912192
BMC Bioinformatics. 2007 Feb 15;8:55
pubmed: 17302974
Diabetes. 2016 Jun;65(6):1472-80
pubmed: 27222391
Diabetologia. 2011 Jul;54(7):1766-76
pubmed: 21472432
PLoS One. 2012;7(1):e29807
pubmed: 22235342
Carcinogenesis. 2007 Nov;28(11):2313-20
pubmed: 17638919
Diabetologia. 2015 Oct;58(10):2307-16
pubmed: 26099855
Am J Transplant. 2013 Jul;13(7):1850-8
pubmed: 23668890
J Endocrinol. 2018 Feb;236(2):R109-R143
pubmed: 29203573
Lung Cancer. 2011 Sep;73(3):302-9
pubmed: 21333374
Endocrinology. 2002 Sep;143(9):3695-8
pubmed: 12193586
Nutr Diabetes. 2013 Oct 21;3:e93
pubmed: 24145577
Diabetes. 2005 Feb;54(2):452-61
pubmed: 15677503
Diabetes. 2005 Dec;54 Suppl 2:S97-107
pubmed: 16306347
Diabetologia. 2005 Jun;48(6):1038-50
pubmed: 15864529
Diabetes Obes Metab. 2008 Nov;10 Suppl 4:23-31
pubmed: 18834430
Trends Endocrinol Metab. 2011 Jul;22(7):266-74
pubmed: 21458293

Auteurs

Mohammed Bensellam (M)

Garvan Institute of Medical Research, Sydney, NSW, Australia. mohammed.bensellam@uclouvain.be.
Université catholique de Louvain, Institut de recherche expérimentale et clinique, Pôle d'endocrinologie, diabète et nutrition, Brussels, Belgium. mohammed.bensellam@uclouvain.be.

Jeng Yie Chan (JY)

Garvan Institute of Medical Research, Sydney, NSW, Australia.
St. Vincent's Clinical School, UNSW Sydney, Sydney, NSW, Australia.

Kailun Lee (K)

Garvan Institute of Medical Research, Sydney, NSW, Australia.

Mugdha V Joglekar (MV)

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

Anandwardhan A Hardikar (AA)

NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

Thomas Loudovaris (T)

St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.

Helen E Thomas (HE)

St. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
St. Vincent's Hospital, The University of Melbourne, Fitzroy, Victoria, Australia.

Jean-Christophe Jonas (JC)

Université catholique de Louvain, Institut de recherche expérimentale et clinique, Pôle d'endocrinologie, diabète et nutrition, Brussels, Belgium.

D Ross Laybutt (DR)

Garvan Institute of Medical Research, Sydney, NSW, Australia. r.laybutt@garvan.org.au.
St. Vincent's Clinical School, UNSW Sydney, Sydney, NSW, Australia. r.laybutt@garvan.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH